• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

进一步的证据表明,肝素的高碘酸盐裂解主要通过抗凝血酶结合位点发生。

Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.

作者信息

Islam Tasneem, Butler Melissa, Sikkander Sulthan A, Toida Toshihiko, Linhardt Robert J

机构信息

Department of Chemistry, Division of Medicinal and Natural Products Chemistry and Department of Chemical and Biochemical Engineering, PHAR S 328, University of Iowa, Iowa City, IA 52242, USA.

出版信息

Carbohydr Res. 2002 Nov 19;337(21-23):2239-43. doi: 10.1016/s0008-6215(02)00229-x.

DOI:10.1016/s0008-6215(02)00229-x
PMID:12433488
Abstract

Porcine mucosal heparin was fragmented into low-molecular-weight (LMW) heparin by treatment of periodate-oxidized heparin with sodium hydroxide, followed by reduction with sodium borohydride and acid hydrolysis. Gradient polyacrylamide gel electrophoresis analysis showed a mixture of heparin fragments with an average size of eight disaccharide units. 1D 1H NMR showed two-thirds of the N-acetyl groups were lost on periodate cleavage, suggesting cleavage had occurred at the glucopyranosyluronic acid (GlcpA) and idopyranosyluronic acid (IdopA) residues located within and adjacent to the antithrombin III (ATIII) binding site. The N-acetyl glucopyranose (GlcpNAc) residue was lost on workup. The GlcpA residue, within the ATIII binding site, is on the non-reducing side of the N-sulfo, 3, 6-O-sulfo glycopyranosylamine (GlcpNS3S6S) residue. Thus, periodate cleaved heparin should be enriched in GlcpNS3S6S residues. Two-dimensional correlation spectroscopy (2D COSY) confirmed that LMW heparin prepared through periodate cleavage contained GlcpNS3S6S at its non-reducing end. As expected, this LMW heparin also showed reduced ATIII mediated anti-factor IIa and anti-factor Xa activities.

摘要

通过用氢氧化钠处理高碘酸盐氧化的肝素,随后用硼氢化钠还原并进行酸水解,将猪黏膜肝素片段化为低分子量(LMW)肝素。梯度聚丙烯酰胺凝胶电泳分析显示肝素片段混合物的平均大小为八个二糖单位。一维¹H NMR显示,在高碘酸盐裂解时,三分之二的N-乙酰基丢失,表明裂解发生在抗凝血酶III(ATIII)结合位点内及相邻的吡喃葡萄糖醛酸(GlcpA)和艾杜糖醛酸(IdopA)残基处。在处理过程中,N-乙酰葡糖胺(GlcpNAc)残基丢失。ATIII结合位点内的GlcpA残基位于N-磺基、3,6-O-磺基吡喃糖胺(GlcpNS3S)残基的非还原端。因此,高碘酸盐裂解的肝素应富含GlcpNS3S6S残基。二维相关光谱(2D COSY)证实,通过高碘酸盐裂解制备的LMW肝素在其非还原端含有GlcpNS3S6S。正如预期的那样,这种LMW肝素还显示出ATIII介导的抗因子IIa和抗因子Xa活性降低。

相似文献

1
Further evidence that periodate cleavage of heparin occurs primarily through the antithrombin binding site.进一步的证据表明,肝素的高碘酸盐裂解主要通过抗凝血酶结合位点发生。
Carbohydr Res. 2002 Nov 19;337(21-23):2239-43. doi: 10.1016/s0008-6215(02)00229-x.
2
Synthesis of heparin fragments. A chemical synthesis of the pentasaccharide O-(2-deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranosyl)-(1-4 )-O-(beta-D-glucopyranosyluronic acid)-(1-4)-O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-glu copyranosyl)-(1-4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1-4)-2-deoxy-2-sulfamido-6-O-sulfo-D-glucopyranose decasodium salt, a heparin fragment having high affinity for antithrombin III.肝素片段的合成。五糖O-(2-脱氧-2-磺酰胺基-6-O-磺基-α-D-吡喃葡萄糖基)-(1→4)-O-(β-D-吡喃葡萄糖醛酸)-(1→4)-O-(2-脱氧-2-磺酰胺基-3,6-二-O-磺基-α-D-吡喃葡萄糖基)-(1→4)-O-(2-O-磺基-α-L-吡喃艾杜糖醛酸)-(1→4)-2-脱氧-2-磺酰胺基-6-O-磺基-D-吡喃葡萄糖十钠盐的化学合成,一种对抗凝血酶III具有高亲和力的肝素片段。
Carbohydr Res. 1986 Mar 15;147(2):221-36. doi: 10.1016/s0008-6215(00)90633-5.
3
Retention of antilipemic activity by periodate-oxidized non-anticoagulant heparins.高碘酸盐氧化的非抗凝血肝素的抗脂活性保留
Arzneimittelforschung. 1986 Apr;36(4):637-42.
4
Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III--effect of platelet factor 4.低分子量肝素催化抗凝血酶III对因子Xa和凝血酶的灭活作用——血小板第4因子的影响
Thromb Haemost. 1991 Oct 1;66(4):435-41.
5
Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources.抗凝血酶III结合位点区域的结构变异及其在不同来源肝素中的出现情况。
Biochemistry. 1990 May 8;29(18):4362-8. doi: 10.1021/bi00470a015.
6
Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.低分子量肝素的寡糖图谱分析:结构与活性差异
J Med Chem. 1990 Jun;33(6):1639-45. doi: 10.1021/jm00168a017.
7
1H NMR spectroscopic studies on the interactions between human plasma antithrombin III and defined low molecular weight heparin fragments.关于人血浆抗凝血酶III与特定低分子量肝素片段之间相互作用的核磁共振氢谱研究。
Biochemistry. 1992 Mar 3;31(8):2286-94. doi: 10.1021/bi00123a011.
8
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.糖解低分子量肝素的结构特征及其肝素裂解酶产生的片段。
Anal Bioanal Chem. 2014 Jan;406(1):249-65. doi: 10.1007/s00216-013-7446-4. Epub 2013 Nov 20.
9
Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasma.在重新钙化的人血浆中测定的肝素抗Xa因子与抗凝血酶活性的比率。
Br J Haematol. 1992 Jun;81(2):255-62. doi: 10.1111/j.1365-2141.1992.tb08217.x.
10
Structure of the antithrombin-binding site in heparin.肝素中抗凝血酶结合位点的结构
Proc Natl Acad Sci U S A. 1979 Jul;76(7):3198-202. doi: 10.1073/pnas.76.7.3198.

引用本文的文献

1
Expanding the Role of Heparin Derivatives in Oncology: From Anticoagulation to Antitumor Activity.扩大肝素衍生物在肿瘤学中的作用:从抗凝到抗肿瘤活性。
Pharmaceuticals (Basel). 2025 Mar 12;18(3):396. doi: 10.3390/ph18030396.
2
Non-Anticoagulant Heparin: An In Vitro Investigation of a Novel Therapeutic Approach for Oral Cancer.非抗凝肝素:口腔癌新型治疗方法的体外研究
Oral Dis. 2025 Jun;31(6):1672-1683. doi: 10.1111/odi.15288. Epub 2025 Mar 3.
3
Acetylation may strengthen the antitumor activity of low molecular heparin.乙酰化可能会增强低分子肝素的抗肿瘤活性。
Transl Cancer Res. 2021 Jan;10(1):461-468. doi: 10.21037/tcr-20-2195.
4
Chemical Modification of Glycosaminoglycan Polysaccharides.糖胺聚糖多糖的化学修饰。
Molecules. 2021 Aug 27;26(17):5211. doi: 10.3390/molecules26175211.
5
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2.硫酸乙酰肝素蛋白聚糖作为新冠病毒的附着因子
ACS Cent Sci. 2021 Jun 23;7(6):1009-1018. doi: 10.1021/acscentsci.1c00010. Epub 2021 Jun 2.
6
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.肝素与严重急性呼吸综合征相关冠状病毒 2(SARS-CoV-2)刺突糖蛋白结合相互作用的表征。
Antiviral Res. 2020 Sep;181:104873. doi: 10.1016/j.antiviral.2020.104873. Epub 2020 Jul 10.
7
Non-Anticoagulant Heparins as Heparanase Inhibitors.非抗凝肝素作为乙酰肝素酶抑制剂。
Adv Exp Med Biol. 2020;1221:493-522. doi: 10.1007/978-3-030-34521-1_20.
8
Non-anticoagulant Heparin as a Pre-exposure Prophylaxis Prevents Lyme Disease Infection.非抗凝肝素作为暴露前预防可预防莱姆病感染。
ACS Infect Dis. 2020 Mar 13;6(3):503-514. doi: 10.1021/acsinfecdis.9b00425. Epub 2020 Jan 30.
9
Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.肝素结合细胞因子及基于肝素类似物的细胞载体
Molecules. 2019 Dec 17;24(24):4630. doi: 10.3390/molecules24244630.
10
Glycosaminoglycan Compositional Analysis of Relevant Tissues in Zika Virus Pathogenesis and in Vitro Evaluation of Heparin as an Antiviral against Zika Virus Infection.寨卡病毒发病机制相关组织中的糖胺聚糖组成分析及肝素作为抗寨卡病毒感染的抗病毒药物的体外评价。
Biochemistry. 2019 Feb 26;58(8):1155-1166. doi: 10.1021/acs.biochem.8b01267. Epub 2019 Feb 13.